共 50 条
- [8] Detyrosinated α-Tubulin, Vimentin and PD-L1 in Circulating Tumor Cells (CTCs) Isolated from Non-Small Cell Lung Cancer (NSCLC) Patients [J]. JOURNAL OF PERSONALIZED MEDICINE, 2022, 12 (02):
- [9] Monitoring PD-L1 positive circulating tumor cells in non-small cell lung cancer patients treated with the PD-1 inhibitor Nivolumab [J]. SCIENTIFIC REPORTS, 2016, 6